PRAX Praxis Precision Medicines
- 79.520
- +2.560+3.33%
- 79.520
- 0.0000.00%
Praxis Precision Medicines News
Praxis Precision Medicines | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Praxis Precision Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Mastrocola Lauren
Praxis Precision Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Kelly Timothy Edwin
Praxis Precision Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Nemiroff Alex
Praxis Precision Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Mastrocola Lauren
Praxis Precision Medicines | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Steven A. Cohen(9.6%),Point72 Asset Management, L.P.(9.3%), etc.
Praxis Precision Medicines | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(5.0%),VHCP Co-Investment Holdings III, LLC(5.0%), etc.
Praxis Precision Medicines | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(4.3%),Peter Kolchinsky(4.3%), etc.
Praxis Precision Medicines | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Asset Management, LP(4.67%),Bihua Chen(4.67%)
Praxis Precision Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Praxis Precision Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Praxis Precision Medicines | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. ROWE PRICE ASSOCIATES, INC.(6.3%)
Praxis Precision Medicines | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Verition Fund Management LLC(1.8%),Nicholas Maounis(1.8%)
Praxis Precision Medicines | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.85%)
Praxis Precision Medicines | SC 13G: Statement of acquisition of beneficial ownership by individuals-Capital Research Global Investors(5.6%)
Praxis Precision Medicines | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adage Capital Management, L.P.(4.81%),Robert Atchinson(4.81%), etc.
Praxis Precision Medicines | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(7.3%)
Praxis Precision Medicines | 10-Q: Q3 2024 Earnings Report
Praxis Precision Medicines | 8-K: Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Praxis Precision Medicines | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.85%)
No Data